Bringing the fundamentals into focus…
Back to Evotec SE
How Evotec SE stacks up
EVO · against 426 other Healthcare companies of similar size
Growth
39/ 100
Below the middle of the pack.
Ranked #215 of 427 · scores higher than 49% of peers
Bars: peers in each 10-point band of the growth score49 peers with a growth score of 30–39, including EVO · Click a bar to see the companies
Why growth scores 39?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 72% of peers. Revenue growth: -1.1% vs peer median 6.1%
- slower revenue growth over three years: weaker than 66% of peers. 3-year revenue growth: 1.6% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = EVO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | EVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 441 reported | -1.1% | 3.1% | 38% | 33% | |
| Earnings per share growthHigher is better · 222 reported | Not reported | 3.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 418 reported | 1.6% | 3.1% | 44% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around EVO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 209 | 365M EUR (≈$401M) | 41 | 44 | |
| 213 | 2.7B CNY (≈$373M) | 40 | 67 | |
| 213 | 86.8B JPY (≈$590M) | 40 | 60 | |
| 215 | 4.8B CNY (≈$667M) | 39 | 51 | |
| 215 | 551M USD | 39 | 27 | |
| 215 | 964M EUR (≈$1.1B) | 39 | 58 | |
| 215 | 16.2B THB (≈$453M) | 39 | 63 | |
| 219 | 6.4B HKD (≈$821M) | 38 | 54 | |
| 219 | 2.0B CNY (≈$284M) | 38 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score